WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 35 filers reported holding WEREWOLF THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,341,373 | -29.8% | 626,810 | 0.0% | 0.24% | -18.4% |
| Q2 2023 | $1,911,771 | +17.3% | 626,810 | 0.0% | 0.30% | +9.9% |
| Q1 2023 | $1,629,706 | +26.8% | 626,810 | 0.0% | 0.27% | -1.4% |
| Q4 2022 | $1,284,961 | -54.5% | 626,810 | 0.0% | 0.28% | -29.6% |
| Q3 2022 | $2,827,000 | +15.8% | 626,810 | +5.0% | 0.39% | +50.2% |
| Q2 2022 | $2,442,000 | -5.0% | 597,003 | +2.2% | 0.26% | -28.1% |
| Q1 2022 | $2,570,000 | -66.7% | 584,203 | -9.9% | 0.36% | -57.2% |
| Q4 2021 | $7,722,000 | -34.6% | 648,391 | -5.8% | 0.85% | -14.5% |
| Q3 2021 | $11,814,000 | -2.0% | 688,475 | -2.5% | 0.99% | +21.8% |
| Q2 2021 | $12,049,000 | – | 706,294 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $10,274,000 | 48.81% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $74,716,000 | 13.89% |
| MPM BioImpact LLC | 2,388,011 | $41,647,000 | 6.84% |
| Soleus Capital Management, L.P. | 563,396 | $9,826,000 | 1.51% |
| RA Capital Management | 4,291,881 | $74,850,000 | 1.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 706,294 | $12,049,000 | 0.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,552,787 | $44,521,000 | 0.79% |
| Nicholas Investment Partners, LP | 294,654 | $5,139,000 | 0.32% |
| Avidity Partners Management LP | 650,265 | $11,341,000 | 0.31% |
| PFM Health Sciences, LP | 400,000 | $6,976,000 | 0.22% |